Equity
€15,509 from €160,788 in 2021
Equity fell by 90% in 1 year.
PERPHARM
Information for creditors
Enterprise Court of Hainaut, Tournai division · Official Gazette of 10-09-2024Appeal or third-party opposition 25-09-2024Filing the claim in RegSol 04-10-2024First verification report 24-10-2024Late claim 04-09-2025
Trustee: John Dehaene. The judgment is more than a year old. A claim can no longer be filed, not even late. The trustee knows whether anything will still be paid out.
Lifetime
17 annual accounts with figures on one time axis, 20 filings since 2003peak €344,900 (2021)
€320,637▼ 7.0%
lowest -€145,279 (2022)
-€145,279▼ €170,045
peak €160,788 (2021)
€15,509▼ 90.4%
€2.0m▲ 18.0%
peak 7.7 FTE (2022)
7.7 FTE▲ 22.2%
Board6 names since 2018
-
Owners
consolidatesRISSPHAR
Documentsfilings and deeds
23-01-2024176 days late
2022financial year
Loss of €145,279Staff from 6.3 FTE to 7.7 FTEEquity from €160,788 to €15,509Debts from €1.7m to €2.0mCash from €32,868 to €173,602
Key points
from the 2022 annual accounts, the last ones filedDebts
€2.0m 99% of the balance sheet
Financial debts 46%Suppliers 21%Taxes and wages 3%Other 30%
Of this, €1.0m falls due within a year.
Filings
20 annual accounts since 2003
Eight of the last ten came late. The 2022 accounts came latest: 176 days after the end of the period.
No score
Recent changes
Listed in the Peppol Directory
Bankruptcy published
Enterprise Court of Hainaut, Tournai division · judgment of 04-09-2024 · Bankruptcy
End of the transfer under court supervision
Enterprise Court of Hainaut, Tournai division · judgment of 04-09-2024 · Judicial reorganisation
Extension
Enterprise Court of Hainaut · judgment of 29-05-2024 · Judicial reorganisation
Official details
Source: KBO- Status
- In bankruptcydeclared bankrupt on 04-09-2024
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 2022
- Establishment unit
- 2.115.106.2797600 Péruwelz, since 13-11-2002
- Financial year end
- 31 December
- Peppol
- Reachable since 12-12-2025
Annual accounts 2022
- ≈ €1.1mestimated
- €2.0m▲ 8.7%
- Employeeson 31-12-2022
- 7▼ 22.2%
- Filing
- Filed on 23-01-2024
Insights on PERPHARM
Equity fell from €160,788 in 2021 to €15,509 in 2022, while debts rose from €1.7m to €2.0m.
On 4 September 2024 the court declared PERPHARM bankrupt. Parent company RISSPHAR is bankrupt too.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about PERPHARM
- What is the company number of PERPHARM?
- The company number of PERPHARM is 0478.611.658. The VAT number is the same number with BE in front: BE 0478.611.658.
- Where was PERPHARM based?
- The last known address of the registered office is Rue Pont-à-la-Faulx 26-28, 7600 Péruwelz.Company details
- What does PERPHARM do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of PERPHARM?
- PERPHARM is a public limited company (NV).
- When was PERPHARM founded?
- PERPHARM was founded on 17-10-2002.
- Is PERPHARM still active?
- A bankruptcy is running. A bankruptcy trustee manages the company.
- How many employees did PERPHARM have?
- PERPHARM had an average of 7.7 full-time equivalents in financial year 2022, according to the filed annual accounts.Financials
- Which joint committee does PERPHARM fall under?
- In its 2022 annual accounts, PERPHARM states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of PERPHARM?
- The turnover in financial year 2022 is ≈ €1.1m. This figure is estimated from the gross margin of €320,637 and 47 comparable companies (NACE 477). It probably lies between €870,000 and €1.8m.
- Is PERPHARM profitable?
- In financial year 2022, PERPHARM made a loss of €145,279.
- Where can I find the annual accounts of PERPHARM?
- PERPHARM filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2022.
Next steps
See what became of the directors' other companies.Supplier due diligence See who ran this company and where its registered office was, on a date of your choice.Company as of a date Check your own customer list for customers at risk.Process a list See how the retail sale of pharmaceutical products sector is doing.Sector figures